Resolutions from Annual General Meeting of Elos Medtech AB (publ) 2022
Elos Medtech held its Annual General Meeting (”AGM”) on Tuesday 3 May 2022. The AGM was carried out, pursuant to temporary statutory rules, through advance voting only, without any physical attendance. The AGM resolved inter alia the following:
Adoption of income statements and balance sheets for 2021 and discharge of liability
The AGM adopted the income statements and balance sheets for the company and the group included in the annual report for the financial year 2021. The AGM resolved to discharge the members of the Board of Directors and the CEO from liability in respect of their management of the company’s business during the financial year 2021.
Allocation of profits
The AGM resolved that no dividend for the financial year 2021 shall be paid to the shareholders and that the company’s unrestricted equity of SEK 287,832,937 shall be carried forward.
Election of Board members and auditor, and determination of remuneration to the Board of Directors and auditor
The AGM resolved, in accordance with the nomination committee’s proposal, that the number of Board Members shall be five (5) without deputies and the number of auditors shall be one (1) without deputies.
The AGM resolved, in accordance with the nomination committee’s proposal, to re-elect Lovisa Lander, Birker B. Bahnsen, Alexander Cicetti and Stefano Alfonsi as members of the Board of Directors. Magnus René was elected new member of the Board of Directors. All elections for the period until the end of the next AGM. Furthermore, Stefano Alfonsi was elected as new Chairman of the Board of Directors. The registered accounting firm KPMG AB was re-elected as the company’s auditor, with the authorized public accountant Johan Kratz as the auditor in charge.
The AGM resolved, in accordance with the nomination committee’s proposal, that remuneration shall be paid with SEK 500,000 to the Chairman of the Board of Directors and with SEK 250,000 to each of the other Board members, and that remuneration for additional efforts of a consultancy nature may be paid to Board members within a framework of SEK 100,000, to be distributed in accordance with the Board of Directors’ decision.
The Board members which are dependent in relation to the majority holder TA Associates shall not receive remuneration.
Furthermore, the AGM resolved, in accordance with the nomination committee’s proposal, that the fee to the auditor shall be paid in accordance with approved invoices.
Principles for the appointment of the Nomination Committee
The AGM resolved, in accordance with the nomination committee’s proposal, to approve the principles for the appointment of the nomination committee, as set out in the notice to the AGM. The principles are the same as last year with the amendment that the principles will apply until further notice.
Approval of the Board of Director’s remuneration report
The AGM resolved to approve the Board of Directors’ remuneration report for the fiscal year 2021.
Minutes from the AGM together with complete decisions will be provided at the company’s webpage, www.elosmedtech.com.
For more information, please contact:
Jodie Gilmore, interim CEO, President & Business Unit Director Orthopedics, +1 901 323 6699, jodie.gilmore@elosmedtech.com
Ewa Linsäter, CFO, +46 76 633 32 33, ewa.linsater@elosmedtech.com
For more information about the Elos Medtech Group, please see www.elosmedtech.com
Tags: